Pre-Markets Keep Optimistic, Earnings Beats for JNJ, PG, ALLY & More

Zacks
22 Jan

Wednesday, January 22, 2025

Ahead of today’s regular stock market trading session, pre-market futures are picking up where they left off Tuesday afternoon: higher. Continued optimism for a pro-growth Trump administration are sending major indexes to loftier reaches: the Dow is currently +145 points (+0.33%), the S&P 500 is +34 (+0.56%) and the Nasdaq +219 points (+1.01%). The small-cap Russell 2000 is slightly lower today (-0.14%) after leading the indexes yesterday.

As we’ve mentioned earlier this week in this space, we are light on economic prints in this holiday-shortened week. Last week brought us all-important CPI, PPI, Retail Sales and Housing Starts data, while next month concludes with two potentially impactful reports: Personal Consumption Expenditures (PCE) and a new interest rate meeting from the Fed, both on Friday. This week, we’ll see U.S. Leading Economic Indicators (LEI) after today’s opening bell, but nothing else on the economic-report agenda.

Q4 Earnings Roundup: JNJ, PG, ALLY & More


It is, however, an important week for calendar Q4 earnings results, including a Netflix NFLX report Tuesday afternoon that was its most positive in recent memory. This morning, if it’s in your bathroom cabinet, its company is probably reporting earnings this morning.

Johnson & Johnson JNJ shares are down slightly in today’s pre-market, after beating estimates slightly on both top and bottom lines for Q4 this morning: earnings of $2.04 per share outpaced the Zacks consensus by 4 cents, while revenues for the quarter reached $22.52 billion — for a modest +0.06% increase over estimates. But revenue guidance is coming in a bit light, sending the stock to give back the +2.44% it has earned year to date. For more on JNJ’s earnings, click here.

Check out the updated Zacks Earnings Calendar here.

Procter & Gamble PG also put up a modest beat on its bottom line — for fiscal Q2, in its case — to $1.88 per share from $1.86 expected, on revenues of $21.88 billion, which outperformed the Zacks consensus by +1.33%. Demand for household goods is reportedly up; the stock is well off its early December all-time high, but still +3.3% in today’s pre-market. For more on PG’s earnings, click here.

Ally Financial ALLY shares are up +10% ahead of today’s open, as its Q4 report this morning easily surpassed expectations on its bottom line: 78 cents per share versus 59 cents projected. Revenues of $2.1 billion beat the Zacks consensus of $2.07 billion. The bank boasted a +95% customer retention rate in the quarter, adding to its +6% gains made, year to date.

Fiber-optics major Amphenol APH posted solid beats on both top and bottom lines this morning, as Q4 earnings of 55 cents per share surpassed estimates by a solid nickel, and revenues of $4.32 billion swept past the $4.03 billion in the Zacks consensus, and was up +29.8% year over year. Shares are doubling their +4.9% gains year to date on the earnings news this morning for the Zacks Rank #2 (Buy)-rated stock.

Questions or comments about this article and/or author? Click here>>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Johnson & Johnson (JNJ) : Free Stock Analysis Report

Netflix, Inc. (NFLX) : Free Stock Analysis Report

Procter & Gamble Company (The) (PG) : Free Stock Analysis Report

Amphenol Corporation (APH) : Free Stock Analysis Report

Ally Financial Inc. (ALLY) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10